Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMNN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,358
Award facts
- Contract value 100% obligated
- $8,358.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,358 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 1, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. No set-aside designation was used for this delivery order, demonstrating the company's competitive capability in unrestricted federal procurement.
The delivery order authorizes DMS Pharmaceutical Group to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The company's comprehensive product portfolio spans branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical devices, including oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. The place of performance is Park Ridge, Illinois, and ultimate completion is scheduled for December 2, 2025. DMS Pharmaceutical Group's established track record on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMNN?
SPE2DU26FEMNN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DU26FEMNN worth?
The government has obligated $8,358 on SPE2DU26FEMNN.
Is contract SPE2DU26FEMNN an order under another contract?
Yes. SPE2DU26FEMNN is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNN competed?
The extent of competition for SPE2DU26FEMNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award